Results 71 to 80 of about 14,207 (206)
Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler [PDF]
, 2012 OBJECTIVE: To evaluate the pharmaceutical equivalence of a test formulation (fixed-dose combination of budesonide and formoterol fumarate in a single capsule dispensed in an Aerocaps® inhaler) in relation to a reference formulation (budesonide and ...
Andrade-lima, Marina +2 more
core +3 more sources
International Journal of COPD, 2022 Donald A Mahler,1 Xiaoli Niu,2 Kathleen L Deering,3 Carole Dembek2 1Geisel School of Medicine, Dartmouth, Hanover, NH, USA and Valley Regional Hospital, Claremont, NH, USA; 2Sunovion Pharmaceuticals Inc., Marlborough, MA, USA; 3EPI-Q, Inc, Oak Brook, IL,
Mahler DA, Niu X, Deering KL, Dembek C
doaj
Pharmaceutical Sciences, 2017 Background: Celecoxib is a non-steroidal anti-inflammatory drug used extensively in the treatment of pain, arthritis, and cancers. However, its administration is limited due to its several disadvantages including gastric irritation and hepatic first pass
Sepideh Mardani 1, Maryam Maghsoodi 2 * , Saeed Ghanbarzadeh 3,4, Ali Nokhodchi 5, Shadi Yaqoubi 6, Hamed Hamishehkar 7 *
doaj +1 more source
ADVANCEMENTS IN DRY POWDER INHALER
Asian Journal of Pharmaceutical and Clinical Research, 2017 The dry powder inhaler (DPI) has become widely known as a very attractive platform for drug delivery. DPIs are being used for the treatment of asthma and chronic obstructive pulmonary disease by many patients. There are over 20 devices presently in the DPI market. DPIs are preferred over nebulizers and pressurized metered dose inhalers.
Ganga Srinivasan, Advait Shetty
openaire +2 more sources
KONA Powder and Particle Journal, 2013 This paper reviews scientific understandings relevant to the dry powder inhaler (DPI) development including turbulent airflow characteristics in the inhaler, microparticle entrainment and deaggregation within the airflow and device.
Zhen Xu, Anthony J Hickey
doaj +1 more source
Inhaler Competence and Patient Satisfaction with Easyhaler: Results of Two Real-Life Multicentre Studies in Asthma and COPD. [PDF]
, 2013 OBJECTIVE: The aim of this study was to investigate patients' inhaler competence and satisfaction with the Easyhaler(R) dry powder inhaler. DESIGN: Two open, uncontrolled, non-randomised studies.
Gabriella Gálffy +6 more
core +2 more sources
Therapeutic Advances in Respiratory Disease, 2016 The treatment of persistent asthma has been aided by the recent approval of new medications. The combined inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) powder inhaler fluticasone furoate (FF)/vilanterol trifenatate (VI) is one of these new ...
Timothy E. Albertson +2 more
doaj +1 more source
Characterization of a Human Powered Nebulizer Compressor for Resource Poor Settings [PDF]
, 2014 Background Respiratory disease accounts for three of the ten leading causes of death worldwide. Many of these diseases can be treated and diagnosed using a nebulizer. Nebulizers can also be used to safely and efficiently deliver vaccines.
Hallberg, Christopher J. +4 more
core +2 more sources
International Journal of General Medicine, 2018 Mira Adhikari Baral Department of Nursing, Pokhara Campus, Tribhuvan University, Institute of Medicine, Pokhara, Nepal Purpose: Dry powder inhalation is a cornerstone of treatment in patients with COPD.
Baral MA
doaj
Dry Powder Inhalation of siRNA [PDF]
Therapeutic Delivery, 2019 Keil, Tobias WM, Merkel, Olivia M
openaire +2 more sources